Session » Miscellaneous Rheumatic and Inflammatory Diseases Poster III
-
Abstract Number: 1830
Characteristics of Arthritis in Familial Mediterranean Fever Patients
-
Abstract Number: 1831
Establishing a Scientific Bridge to Historic VIOXX to Enable a Reintroduction of Rofecoxib: Pharmacokinetic Evaluation of TRM‑201 (Rofecoxib)
-
Abstract Number: 1832
Efficacy and Safety Similarity of Biosimilar Adalimumab-aqvh to Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Phase III Study
-
Abstract Number: 1833
Intraarticular Morphine in Knee-arthritis – Results of a Randomized Placebo-controlled Trial
-
Abstract Number: 1834
Canakinumab Treatment in Familial Mediterranean Fever Patients with Colchicine Resistance: A Single-center Study
-
Abstract Number: 1835
Clinical Features of Patients with Sarcoidosis and Concomitant Connective Tissue Disease
-
Abstract Number: 1836
Schizophrenia and Its Relationship with Autoimmunity: A Nationwide Analysis
-
Abstract Number: 1837
Eales Disease and Vogt-Koyanagi-Harada Syndrome: Not Everything Is Anterior Uveitis in Rheumatology
-
Abstract Number: 1838
Real-World Treatment Patterns Among Adult Patients with Dermatomyositis in the United States
-
Abstract Number: 1839
Appendicitis Still a Challenge for FMF Patients?
-
Abstract Number: 1840
The 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease Perform Lower Than Expected: Data from a Norwegian Cohort
-
Abstract Number: 1841
To Combine or Not to Combine: Influence of Immunosuppressive Drug Combination in the Induction of Therapeutic Response in Non-infectious Uveitis
-
Abstract Number: 1842
Vaccination in Patients with Autoinflammatory Periodic Syndromes Under Canakinumab – Safety Data Interim Analysis of the RELIANCE Registry
-
Abstract Number: 1843
Trends in the Cumulative Exposure to Corticosteroids in Polymyalgia Rheumatica (PMR) Patients: A Single Academic Center Experience
-
Abstract Number: 1844
Biological Therapy in Neurosarcoidosis: Study of 30 Patients from a Series of 234 Systemic Sarcoidosis from a University Hospital
-
Abstract Number: 1845
Mortality Prognostic Factors of Critically Ill Patients with Systemic Autoimmune Diseases Admitted in a Medical Intensive Care Unit: A 20-year Cohort Study
-
Abstract Number: 1846
Cardiac Sarcoidosis: An Underdiagnosed, Life-threatening yet Treatable Disease
-
Abstract Number: 1848
Characterizing Nailfold Capillary Changes in Dermatomyositis with a Dermatoscope
-
Abstract Number: 1849
Characteristics of Patients with Primary Retinal Vasculitis at a Tertiary Referral Center
-
Abstract Number: 1850
Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
-
Abstract Number: 1851
Phenotype and Genotype of Adult-onset Adenosine Deaminase 2 Deficiency Patients
-
Abstract Number: 1852
Clinical Efficacy and Safety of Guselkumab Maintenance Therapy in Patients with Moderately to Severely Active Crohn’s Disease: Week 48 Analyses from the Phase 2 GALAXI 1 Study
-
Abstract Number: 1853
A Comparitive Study of NLRP3- and NLRP12-autoinflammatory Disease